Anika Therapeutics (NASDAQ:ANIK – Get Rating) posted its earnings results on Thursday. The biotechnology company reported ($0.20) EPS for the quarter, beating the consensus estimate of ($0.24) by $0.04, MarketWatch Earnings reports. Anika Therapeutics had a negative return on equity of 0.11% and a net margin of 2.80%. During the same period in the prior […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Riverwater Partners LLC purchased a new position in shares of Anika Therapeutics, Inc. (NASDAQ:ANIK – Get Rating) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 9,096 shares of the biotechnology company’s stock, valued at approximately $326,000. Riverwater Partners LLC […]